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ABSTRACT 
 
Fear extinction models have a key role in our understanding of anxiety disorders and their 
treatment with exposure therapy. Here, we tested whether individual differences in fear 
extinction learning and fear extinction recall in the laboratory were associated with the 
outcomes of an exposure therapy analog (ETA). Fifty adults with fear of spiders participated 
in a two-day fear-learning paradigm assessing fear extinction learning and fear extinction 
recall, and then underwent a brief ETA. Correlational analyses indicated that enhanced 
extinction learning was associated with better ETA outcome. Our results partially support the 
idea that individual differences in fear extinction learning may be associated with exposure 
therapy outcome, but suggest that further research in this area is needed.  
 
 
Key words: fear learning, fear conditioning, extinction learning, extinction recall, exposure 
therapy, anxiety disorders. 
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INTRODUCTION 
Fear learning models are important for our understanding of anxiety disorders and their 
treatment (Graham & Milad, 2011; VanElzakker, Kathryn Dahlgren, Caroline Davis, Dubois, 
& Shin, 2014). In a typical fear learning experiment, an initially neutral stimulus (conditioned 
stimulus, CS) elicits a conditioned fear response (CR) and generates a fear memory 
(conditioning) after being repeatedly paired with an aversive unconditioned stimulus (US). In 
humans, most fear learning experiments use a differential conditioning paradigm, where one 
CS (CS+) is followed by the US and another is not (CS-).  
After conditioning, if the CS is presented repeatedly without the US, the CR decays 
and a safety memory is formed (extinction learning). In experiments where conditioning and 
extinction learning occur in different contexts, if the CS is presented later in the context 
where extinction learning took place, this extinction memory is expressed again (extinction 
recall).  
Abnormalities in some of these fear-learning processes could characterize anxious 
individuals in comparison to healthy controls and be a hallmark of anxiety disorders. For 
example, impaired extinction learning has been observed in individuals with panic disorder or 
generalized anxiety disorder (Michael, Blechert, Vriends, Margraf, & Wilhelm, 2007; Otto et 
al., 2014, Pitman & Orr, 1986), while impaired extinction recall could characterize 
individuals with post-traumatic stress disorder (Milad et al., 2008). Several theories have 
been proposed to explain the association between fear learning and anxiety disorders,  
including failure to inhibit fear to safety cues (Davis, Falls & Gewirtz, 2000), deficits in 
associative learning (Grillon, 2002), stimulus generalization (Mineka & Zinbarg, 1996), and 
enhanced conditionability (Orr et al., 2000) (reviewed by Lissek et al., 2005). 
Apart from their possible role in the origin of anxiety disorders, fear-learning 
variables may have also an important role in the treatment of these disorders. In fact, there are 
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many similarities between exposure therapy and fear extinction learning. Exposure therapy 
(one of the central components of cognitive-behavioral therapy -CBT- for anxiety-related 
disorders) uses extinction learning principles by having the patient repeatedly confront a 
feared situation (CS) in the absence of danger (US) until fear diminishes (Myers & Davis, 
2007). Moreover, extinction learning models may explain the mechanisms through which 
exposure therapy acts. For example, according to the inhibitory learning theory the original 
CS-US association learned during fear conditioning is not erased during fear extinction 
learning, but rather a new association (that the CS no longer predicts the US) is developed 
(Craske et al., 2008). 
Research on fear extinction has gained momentum in recent years thanks to the 
exciting possibilities offered by translational research (Kindt, 2014; Milad & Quirk, 2012; 
Morrison & Ressler, 2014). Neuroimaging studies have shown that structural or functional 
variability in brain areas related to fear extinction is associated with the outcome of exposure 
therapy/CBT (Bryant et al., 2008; Fullana et al., 2014; Hoexter et al., 2013). Moreover, new 
pharmacological (Singewald, Schmuckermair, Whittle, Holmes, & Ressler, 2015) and 
behavioral (Schiller et al., 2010) approaches have been developed that focus on optimizing 
fear extinction abilities.  
An important assumption from this research is that extinction learning in the 
laboratory is (almost) equivalent to exposure therapy (Berry, Rosenfield, & Smits, 2009; 
Hermans, Craske, Mineka, & Lovibond, 2006), and that the former should predict the latter 
(i.e. enhanced extinction learning would be associated with better outcomes from exposure 
therapy); however, this assumption has rarely been tested. One exception is a recent study by 
Waters and Pine (2016), who assessed fear conditioning and extinction learning in the 
laboratory using a differential conditioning paradigm and evaluative ratings (arousal and 
valence) and skin conductance responses (SCR) as measures of fear in a group of clinically 
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anxious children who then underwent CBT. The results showed that, during extinction 
learning, treatment non-responders did not show a significant decrease in fear (measured with 
the SCR) compared to responders and healthy controls. Waters and Pine (2016) assessed fear 
learning psychophysiologically using the SCR, and there is evidence that fear-potentiated 
startle (FPS) could be a more selective (i.e. less sensitive to declarative knowledge) measure 
of fear (Hamm & Weike, 2005; Sevenster, Beckers, & Kindt, 2014; but see Luck & Lipp, 
2015; Purkis & Lipp, 2001). Moreover, this study did not assess fear extinction recall, which 
may also be associated with exposure therapy outcomes (Milad & Quirk, 2012). Finally, it is 
not clear whether these findings can be replicated in adults, which is important because 
translational evidence suggests that extinction learning capacities may change over the life 
span (Baker, Bisby, & Richardson, 2016; Pattwell et al., 2012). 
Another recent study by Ball, Knapp, Paulus, & Stein (2016) explored the link 
between extinction learning and exposure therapy in a sample of 24 adults with public 
speaking anxiety. Brain activation and subjective ratings were assessed during extinction 
learning, and self-reported anxiety changes were collected during a massed exposure session, 
mimicking exposure therapy. Results showed that those with better extinction learning and 
changes in activation in brain regions associated with fear extinction (ventromedial prefrontal 
cortex, amygdala, insula, and periaqueductal gray) reported greater anxiety reduction during 
exposure therapy. This study focused only on extinction learning and did not assess 
extinction recall. Moreover, Ball et al. (2016) did not use psychophysiological measures of 
fear learning or anxiety reduction.  
In the present study, we used a differential conditioning paradigm in adults with fear 
of spiders to test the hypothesis that individual differences in fear extinction in the laboratory 
would be associated with the outcome of an analog of exposure therapy (exposure therapy 
analog, ETA). Specifically, we expected that an enhanced fear extinction learning and fear 
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extinction recall would be associated with a greater fear reduction from pre- to post-ETA. 
Following previous research (e.g. Pineles et al., 2016; Rabinak et al., 2013), we 
operationalized fear extinction as the difference between the CS+ and CS- during extinction 
learning and extinction recall. 
 
MATERIALS AND METHODS 
See Figure 1 for a summary of the experimental design.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Summary of experimental design.  
US: Unconditioned stimulus; SCR: Skin Conductance Response; FPS: Fear-Potentiated startle; CS+, Conditioned stimulus associated with 
the unconditioned stimulus during the conditioning phase; CS-, Conditioned stimulus never associated with the unconditioned stimulus. 
 
 
Participants 
We selected individuals with moderate to strong fear of spiders, as assessed by a dimensional 
instrument. Participants were recruited by advertisements to participate in a study on 
“physiological responses to anxiety”. Initially, 1504 individuals were screened with the 
validated Spanish version (Forcadell, Torrents-Rodas, Martinez, Torrubia, & Fullana, 2014) 
Eduard Forcadell   7 
 
of the Fear of Spiders Questionnaire (FSQ; Szymanski & O’Donohue, 1995) via a secure 
web system. Participants who scored in the top quartile of the study distribution (FSQ≥33; 
n=386) were invited to participate. Of those, 92 accepted to be interviewed by a doctoral-
level clinical psychologist using the Mini International Neuropsychiatric Interview (MINI; 
Sheehan et al., 1998).  
Exclusion criteria were: (a) current or lifetime history of mental disorders other than 
specific phobia (animal type, spiders), as determined by the MINI, supplemented with the 
specific phobia section of the Structured Clinical Interview for DSM (SCID; First, Spitzer, 
Gibbon, & Williams, 2002); (b) use of medication/illicit drugs or medical problems that 
could interfere with study performance or interpretation; (c) alcohol abuse; (d) pregnancy; (e) 
not being Spanish-speaker. Female participants had regular menstrual cycles (self-report), 
had not used oral contraceptives or hormone replacement therapy during the previous three 
months, and participated in the study during their early follicular phase (days 3-8 of a 28 to 
30-day cycle) to avoid possible confounding by sex hormones in fear extinction (Merz et al., 
2012; Milad et al., 2006; Pineles et al., 2016). All participants were tested between 5 and 8 
PM. 
The final sample consisted of 50 participants with moderate to strong fear of spiders 
(MFSQ = 58.98, SD = 17.94; Mage = 21.50 years, SD = 2.93; 25 women). Participants gave 
written informed consent to take part in the study, which was approved by the corresponding 
institution’s Clinical Research Ethics Committee. Participants were paid €25. 
 
Procedure overview 
Participants took part in two experimental sessions on two consecutive days. On day one, 
they rated their fear of spiders (FSQ pre-ETA score), participated in the first part of the fear 
learning paradigm (conditioning and extinction learning), and selected the two phobic stimuli 
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(two most fearful images from a pre-selected set of 30 spider images; see Supplementary 
Materials-Methods) that would be used during ETA. On day two they participated in the 
second part of the fear learning paradigm (extinction recall), underwent ETA, and rated their 
fear of spiders again (FSQ post-ETA score). Psychophysiological responses were recorded 
continually during the fear learning paradigm and during ETA (see below). 
 
Fear learning paradigm 
We adapted the paradigm developed by Milad, Orr, Pitman, and Rauch (2005), which allows 
us to assess conditioning, extinction learning, and extinction recall separately. The original 
task used SCR as the only measure of conditioned fear, but we added two other measures (US 
expectancies and FPS) (see Supplementary Materials-Methods). Briefly, the visual contexts 
were photographs of two different rooms (conditioning context, CX+; extinction context, 
CX-) containing a lamp that switched on to one of two different colors (blue or yellow), 
which were the CSs (CS+ and CS-). Contexts and CSs were displayed on a computer monitor 
in front of the participant. On day 1, a conditioning phase (in CX+) was followed by an 
extinction learning phase (in CX-). During conditioning, the CS+ co-terminated with an 
electric shock (US). The US was individually adjusted before the experiment (day 1) 
presenting shocks of gradually increasing intensity until a ‘definitely annoying but not 
painful’ shock was selected (Mshock level = 4.9 milliamperes (mA), SD = 3.3). Participants were 
not instructed about the CS-US contingency. During extinction learning (immediately after 
conditioning), the CS+ was not followed by the US. The CS– was never followed by the US. 
The extinction learning phase was divided in two equal parts by a 1-minute pause (early and 
late extinction learning). Day 2 consisted of an extinction recall phase in CX-. During day 2, 
the CS+ and the CS– were never followed by the US. The US was not recalibrated during day 
2. 
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Each trial of the experiment started with presentation of the context for 10, 12 or 14 s. 
Then the CS was presented (i.e. the lamp switched on) for 8 s, and a startle probe (50 ms 
duration, 100 dB) was delivered 7 s after CS onset. Between trials, a fixation cross was 
shown for 1 s. In one third of the trials (noise-alone trials, NA), no CS was presented, and 
instead the context was present for 8 more seconds; the startle probe was presented at second 
7 of this extra time. The inter-probe interval varied between 18, 20, and 22 s. Eight trials of 
each type (CS+, CS–, and NA) were presented during conditioning, and six trials of each 
were presented during each of the remaining phases (early and late extinction learning, and 
extinction recall). SCR, FPS and US expectancy ratings were calculated for each trial type.  
The SCR signal was sampled at a rate of 125 Hz. SCR magnitudes were computed in 
microsiemens (μS) as the difference between the maximum SCR value and the value at 
response onset, occurring 1 to 7 s after CS onset. Trials in which no response was detected or 
with a response magnitude of < 0.02 μS were considered non-response trials (see Dunsmoor, 
Mitroff, & LaBar, 2009), and trials showing interference or excessive baseline activity (1.3%) 
were rejected after visual inspection. To normalize the distribution of the SCR data, we 
applied a square root transformation. 
 Startle amplitudes were computed in microvolts (µV) as the difference between the 
EMG value at response peak and the average EMG during the 50 ms preceding the probe. If 
no response was detected in a given trial, the amplitude was scored as 0 µV. To be considered 
a valid response, elevations in the EMG recording had to start between 20 and 100 ms, and 
their peak had to occur between 20 and 150 ms after the probe. After visual inspection, trials 
with excessive noise (3.2%) were rejected. Raw data were transformed into T-scores to 
control for differences in reactivity. Scorers of SCR and FPS data were blind to the stimuli 
presented. 
 Regarding US expectancy ratings, for each trial participants were told to try to predict 
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whether the shock would occur in the following seconds each time the lamps in the rooms 
turned blue or yellow. They had to answer as quickly as possible by clicking on the scale 
from 0 (no shock) to 10 (shock) displayed at the bottom of the screen (see Supplementary 
Materials-Methods for further information).  
 
Fear extinction indices 
Based on previous literature (Garfinkel et al., 2014; Pineles et al., 2016; Rabinak et al., 2013, 
2014), we calculated for each participant and for each measure (US expectancies, SCR and 
FPS) an index expressing the “amount of learning” reflecting differences between CS+ and 
CS- during extinction learning (using early extinction and operationalized as a percentage), 
and extinction recall (using the first two trials) (see Supplementary Materials Table S1). 
Since the extinction learning index was calculated as a percentage, higher scores indicated 
enhanced extinction learning (i.e. less discrimination between CS+ and CS-). Since the 
extinction recall index was calculated as a simple subtraction it had the opposite 
interpretation (i.e. lower scores indicated enhanced extinction recall).  
 
Exposure therapy analog (ETA) 
We developed a one-session computer-assisted ETA based on exposure therapy principles 
(i.e. repeated presentation of phobic stimuli). Single-session exposure therapy (Tsao & 
Craske, 2000; Vasey, Harbaugh, Buffington, Jones, & Fazio, 2012), including computer-
assisted protocols (Andersson et al., 2009; Dewis et al., 2001; Gilroy et al. 2000; Heading et 
al., 2001; Müller, Kull, Wilhelm, & Michael, 2011), are effective for treating specific fears 
and phobias. Our ETA was very similar to that used by Müller et al. (2011) in a randomized 
controlled trial, and similar effect sizes in fear reduction (see below) as those obtained by 
Müller et al. (2011) were also observed in the present study. 
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 During ETA, participants were presented on a computer screen with the two 
previously selected phobic images (10 minutes each for a total of 20 minutes) and two neutral 
images (of a pen and a fork; 2,5 minutes each for a total of 5 minutes; see Supplementary 
Material-Methods). Neutral and phobic images were interleaved and presented 10 times each. 
To avoid order effects, participants were randomized into two groups that began with either a 
phobic or a neutral image. Neutral images were included to confirm that phobic images were 
subjectively and psychophysiologically more aversive.  
Participants received brief psychoeducation in which they were instructed to confront 
phobic stimuli without using overt (i.e. avoid looking) or covert (i.e. distracting) avoidance 
behaviors. We assessed SCR, FPS and subjective responses (using a visual analog scale, 
VAS) during ETA. SCR and FPS responses for each stimulus during ETA were quantified 
off-line using the same procedures as for the fear learning paradigm, with the exception that 
for the SCR, due to design constraints, we used the maximum score occurring at 1 to 6s (not 
1 to 7s) after onset of the stimulus. We obtained 20 SCR scores for the phobic and 20 for the 
neutral stimuli. Two startle probes were presented at the end of each image, with an inter-
probe interval of 8, 9, 10, 12, or 14s. These two scores were averaged to obtain 20 FPS scores 
for the phobic and 20 for the neutral stimuli (see Supplementary Materials-Methods for 
further information). 
 
ETA outcome variables 
We evaluated ETA outcomes using three different measures of fear reduction, where higher 
scores indicated greater fear reduction:  
FSQ: Difference between pre- and post-ETA, as measured by the FSQ.  
ABS-Fear reduction: Absolute difference between the first response (average of the 
first two responses to phobic image 1 and phobic image 2) and the last response (average of 
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the last two responses to phobic image 1 and phobic image 2) for VAS, SCR and FPS 
responses during ETA. 
% Fear reduction: Percentage of fear reduction for VAS, SCR and FPS obtained by 
dividing the last response during ETA (average of phobic image 1 and phobic image 2) by the 
first response during ETA (average of phobic image 1 and phobic image 2), multiplied by 
100 and then subtracted from 100%.  
 
Statistical analyses 
In preliminary analyses, we tested for differences in responses to phobic and neutral 
stimuli during ETA using three separate (VAS, SCR, and FPS) repeated-measures t-tests. We 
also assessed the effectiveness of ETA on fear reduction using four separate (FSQ, VAS, 
SCR, and FPS) repeated-measures t-tests to compare pre- and post-ETA scores. We report 
Cohen's d (calculated as the difference between means divided by the standard deviation) as 
an estimate of effect size for these analyses. We studied the performance of the sample during 
the fear learning paradigm using repeated-measures ANOVA for each phase (conditioning, 
extinction learning and extinction recall) and for each measure (US expectancies, SCR and 
FPS), with CS type (CS+ vs. CS–) and Block as within-subjects factors. We averaged SCR 
and FPS responses over two consecutive trials of the same type (blocks), and applied 
Greenhouse–Geisser corrections for main effects and interactions involving repeated 
measures. We report   
  as an estimate of effect size for these analyses. 
We used Pearson correlations to test the significance of associations between fear 
extinction indices and ETA outcome for the whole sample. Following our main hypothesis, 
we expected our extinction learning index to be positively correlated and our extinction recall 
index to be negatively correlated with ETA outcome.  
Eduard Forcadell   13 
 
Finally, following recent guidelines for the analyses of fear learning data in humans 
(Lonsdorf et al., 2017), we repeated our extinction learning analyses using only those 
participants showing evidence of conditioning (i.e., one participant was excluded for the US 
expectancies analyses, 23 for SCR, and 21 for FPS). Similarly, we calculated extinction recall 
only for participants who showed evidence of extinction learning (i.e., five participants were 
excluded for the US expectancies analyses, 32 for SCR, and 35 for FPS) (see Supplementary 
Materials for the criteria of "successful" conditioning and extinction learning). 
 
RESULTS 
Preliminary analyses 
As expected,  phobic stimuli were more fearful than neutral stimuli, both subjectively (Mphobic 
= 4.37, SD = 2.25; Mneutral = .03, SD = .09; t(49)= 13.65; p< .001; d = 2.38) and 
psychophysiologically  [SCR (Mphobic = .47, SD = .17; Mneutral = .29, SD = .15; t(49)= 10.59; 
p< .001; d = 1.12); FPS (Mphobic = 50.77, SD = 1.89; Mneutral = 49.32, SD = 1.85; t(49)= 2.74; 
p = .009; d = 0.78)]. 
ETA was effective in reducing fear (see Figure 2), as indicated by a significant pre-
post ETA reduction in FSQ (Mpre = 46.54, SD = 23.78; Mpost = 40.38, SD = 26.38; t(49)= 
2.70; p = .009; d = 0.25) and VAS scores (Mpre = 5.76, SD = 2.22; Mpost = 3.30, SD = 2.37; 
t(49)= 11.40; p< .001; d = 1.07), as well as in SCR (Mpre = .69, SD = .20; Mpost = .37, SD = 
.17; t(49)= 12.16; p< .001; d = 1.72) and FPS responses (Mpre = 53.15, SD = 6.36, Mpost = 
49.48, SD = 5.67; t(49)= 2.71; p = .009; d = 0.61). 
 For all measures (US expectancies, SCR, and FPS) and for the whole sample, we 
found evidence of successful conditioning (i.e. higher response to the CS+ than to the CS- in 
the last block of conditioning), as shown by a significant main effect of CS type (ps < .001) 
and significant [US expectancies: F(2.71, 130.23) = 79.76, p< .001,   
  = .62; SCR:  F(2.87, 
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136.17) = 3.59, p = .021,   
  = .07] or almost significant (FPS: F(2.31, 101.48) = 2.66, p = 
.072,   
  = .06) CS type × Block interactions, as well as follow-up analyses indicating larger 
responses to the CS+ than to the CS-  in the last block of conditioning (ps < .001; ds ranging 
from 0.62 to 4). For SCR and FPS and for the whole sample there was evidence of successful 
extinction learning (i.e. similar response to the CS+ and CS- in the last block of extinction), 
as evidenced by a non-significant CS type main effect and a non-significant CS type × Block 
interaction (ps> .108). Analyses of US expectancies for the whole sample revealed a main 
effect of CS type, F(1, 48) = 7.04, p = .011,   
  = .128, but a non-significant CS type × Block 
interaction (p= .080). For FPS and for the whole sample, there was evidence of successful 
extinction recall (i.e. similar response to the CS+ and CS- in the extinction context during the 
first block of extinction recall), as shown by a non-significant CS type main effect and a non-
significant CS type × Block interaction (ps = .277). For US expectancies and SCR we found 
no evidence of extinction recall for the whole sample [significant CS type × Block interaction 
for US expectancies: F(2, 96) = 14.77, p< .001,   
  = .24; and for SCR: F(2, 96) = 4.92, p = 
.009,   
  = .09]. 
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Fig. 2. Effectiveness of ETA (exposure therapy analog) on different outcome measures: (a) Fear of Spiders 
Questionnaire (FSQ), (b) Visual Analog Scale (VAS), (c) Skin Conductance Response (SCR), and (d) Fear-
Potentiated startle (FPS). Bars represent standard errors of the mean. Asterisks indicate significant differences, * 
p< .05 
 
Fear extinction indices and ETA outcome 
Consistent with our hypothesis, our index of fear extinction learning (as measured with US 
expectancies) was positively associated with one of our measures of fear reduction (ABS-
Fear reduction), i.e. predicted a greater fear reduction from pre-to post-ETA. The extinction 
recall index was, however, not significantly associated with ETA outcome (see Table 1). 
Results did not change when we conducted partial correlations controlling for the intensity of 
the US (data not shown). 
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Table 1. Correlations between fear extinction indices and ETA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ETA: Exposure therapy analog; US: Unconditioned stimulus; SCR: Skin Conductance Response; FPS: Fear-Potentiated startle; VAS: Visual 
Analog Scale; FSQ: Fear of spiders questionnaire; % Fear reduction: Percentage of fear reduction; ABS-Fear reduction: Absolute fear 
reduction. Significant values in bold. 
 
Additional analyses 
We repeated the analyses related to ETA outcome described above excluding individuals who 
showed no conditioning for the extinction learning analyses, or those who did not show 
extinction learning for the extinction recall analyses (Table 2). We replicated the significant 
positive correlation between extinction learning (measured with US expectancies and FPS) 
and ABS-Fear reduction (r = .358, p = .032; r = .667, p = .013) and we also found a 
significant positive correlation between extinction learning and % Fear reduction as measured 
with FPS, r = .704, p = .007). Unexpectedly, in these additional analyses our index of fear 
extinction recall (as measured with FPS) was positively associated with ABS-Fear reduction 
(r = .527, p = .044) and % Fear reduction (r = .548, p = .035) (i.e. those showing less 
 
 
 
ETA outcome variables 
 
Pearson correlation 
 
p 
EXTINCTION LEARNING    
US expectancies FSQ-Fear reduction -0.098 0.563 
 ABS-Fear reduction (VAS) 0.338 0.041 
 % Fear reduction (VAS) 0.242 0.149 
SCR FSQ-Fear reduction -0.154 0.530 
 ABS-Fear reduction (SCR) -0.096 0.697 
 % Fear reduction (SCR) -0.060 0.808 
FPS FSQ-Fear reduction 0.256 0.250 
 ABS-Fear reduction (FPS 0.039 0.863 
 % Fear reduction (FPS 0.061 0.787 
EXTINCTION RECALL    
US expectancies FSQ-Fear reduction 0.069 0.635 
 ABS-Fear reduction (VAS) 0.276 0.052 
 % Fear reduction (VAS) 0.171 0.236 
SCR FSQ-Fear reduction -0.002 0.988 
 ABS-Fear reduction (SCR) -0.132 0.361 
 % Fear reduction (SCR) -0.100 0.503 
FPS FSQ-Fear reduction -0.018 0.903 
 ABS-Fear reduction (FPS) 0.137 0.342 
 % Fear reduction (FPS) 0.145 0.316 
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extinction recall showed greater fear reduction from pre- to post-ETA). We also repeated our 
correlational analyses excluding one possible outlier (a participant with a pre-post ETA 
change score in the FSQ 2 standard deviations above the mean) and our results remained 
unchanged.  
 
Table 2. Correlations between fear extinction indices and ETA. Results excluding 
individuals without successful fear conditioning and extinction learning. 
 
 
 
 
 
 
 
 
 
 
 
 
 
ETA: Exposure therapy analog; US: Unconditioned stimulus; SCR: Skin Conductance Response; FPS: Fear-Potentiated startle; VAS: Visual 
Analog Scale; FSQ: Fear of spiders questionnaire; % Fear reduction: Percentage of fear reduction; ABS-Fear reduction: Absolute fear 
reduction. Significant values in bold. 
 
Finally, since there is a lot of variability in how researchers have operationalized and 
calculated fear-learning indices, we calculated alternative fear extinction indices 
(Supplementary Materials-Table S2). We found that two alternative indices of extinction 
recall (based on Pineles et al., 2016) were positively correlated with ABS-Fear reduction 
  
ETA outcome variables 
 
Pearson correlation 
 
p 
EXTINCTION LEARNING    
US expectancies FSQ-Fear reduction -0.111 0.521 
 ABS-Fear reduction (VAS) 0.358 0.032 
 % Fear reduction (VAS) 0.266 0.117 
SCR FSQ-Fear reduction 0.119 0.761 
 ABS-Fear reduction (SCR) 0.409 0.275 
 % Fear reduction (SCR) 0.298 0.436 
FPS FSQ-Fear reduction 0.007 0.982 
 ABS-Fear reduction (FPS) 0.667 0.013 
 % Fear reduction (FPS) 0.704 0.007 
EXTINCTION RECALL    
US expectancies FSQ-Fear reduction 0.023 0.883 
 ABS-Fear reduction (VAS) 0.246 0.103 
 % Fear reduction (VAS) 0.151 0.323 
SCR FSQ-Fear reduction 0.367 0.134 
 ABS-Fear reduction (SCR) -0.109 0.667 
 % Fear reduction (SCR) -0.161 0.551 
FPS FSQ-Fear reduction 0.005 0.985 
 ABS-Fear reduction (FPS) 0.527 0.044 
 % Fear reduction (FPS) 0.548 0.035 
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(extinction recall: r = .325, p = .021; r = .305, p = .031). When we excluded participants 
individuals without successful fear conditioning and extinction learning, none of these 
alternative indices was significantly associated with ETA outcome, except an extinction 
learning index using SCR (based on Rabinak et al., 2014), which was positively associated 
with % fear reduction (r = .455, p = .022).  
 
DISCUSSION 
In this study, we examined the association between fear extinction in the laboratory and the 
outcomes of an ETA. Our analyses suggest that individual differences in fear extinction may 
be associated with fear reduction during an ETA, although they seem to diminish previous 
assumptions about the magnitude of the association between extinction and exposure therapy. 
We found the expected association and in the expected direction for fear extinction learning, 
i.e. individuals with higher extinction learning capacity (as assessed by the discrimination 
between the CS+ and CS-) showed greater fear reduction from pre- to post-ETA. However, 
these results must be interpreted with caution since they were obtained only for some of our 
fear measures (US expectancies for the whole sample analyses, and US expectancies and FPS 
when we excluded individuals without successful fear conditioning and extinction learning). 
 Our results are partially in agreement with Water and Pine (2016), who found that 
individual differences in fear extinction learning might moderate response to CBT. However, 
there are important methodological differences between the studies: we tested healthy 
individuals in a purely experimental setting and using an analog of exposure therapy, whereas 
Waters and Pine (2016) tested anxious children in a clinical setting and using a 10-week 
group-based CBT program. We also used a different fear-learning paradigm. Our results are 
also consistent with those of Ball et al. (2016), who found that individuals with fear of public 
speaking and higher extinction learning reported better outcomes during a massed exposure 
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therapy session. However, we note some differences here, in that Ball et al. (2016) did not 
assess fear extinction recall and did not explore psychophysiological variables. 
Taken together, these results seem consistent with models that consider extinction 
learning to be a central process to exposure therapy (e.g. Craske, Liao, & Vervliet, 2012), and 
support the predictive validity of the fear extinction model in anxiety disorders (Vervliet & 
Raes, 2013). From a clinical perspective, our results indicate that laboratory studies of 
extinction learning may indeed provide insights into exposure therapy, e.g. by helping to 
identify patients who will benefit or not from exposure-based therapies, and thereby adapt 
therapeutic strategies. Moreover, these results support current translational efforts to “boost” 
fear extinction learning as a way to improve CBT therapeutic outcomes (Fitzgerald, 
Seemann, & Maren, 2014; Pittig, van den Berg, & Vervliet, 2015; Rodrigues et al., 2014).  
Unexpectedly, in our additional analyses, we found that enhanced extinction recall 
was associated with a more negative outcome during the ETA. This contrasts with a previous 
report showing association between enhanced extinction recall and a positive CBT outcome 
in social anxiety disorder (Berry et al., 2009). However, there are important differences 
between our experimental measure of extinction recall (focusing on discriminative learning 
between a CS+ and CS-) and that used by Berry et al. (2009), which focused on between-
session fear reduction. Moreover, in previous experimental fear-learning studies, the 
operationalization of extinction recall has varied a lot, and it is possible that the different 
ways of measuring the process affect its association with other variables. Notably, when we 
used alternative indices of extinction recall, the direction of the association (greater extinction 
recall = more negative outcome) remained the same. A previous study in patients with 
obsessive-compulsive disorder (OCD) (Milad et al., 2013) found that OCD severity was 
positively correlated with extinction recall (i.e. better extinction recall was associated with 
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higher severity), which is also counterintuitive. Therefore, clarifying the association between 
fear extinction recall and therapy outcome is an important topic for future research.  
The finding that extinction learning has a different predictive capacity than extinction 
recall is consistent with neurobiological studies showing that these two processes are 
independent (Milad et al., 2007; Phelps, Delgado, Nearing, & Ledoux, 2004; Quirk & 
Mueller, 2008). Moreover, from a methodological perspective, the fact that extinction 
learning may predict ETA outcomes could make the assessment of extinction recall 
redundant. This is important because of the time cost of separate experimental sessions to 
assess extinction recall.  
Furthermore, some measures in our study (e.g. US expectancies) had a better 
predictive value than others (e.g. SCR). This is consistent with many previous fear-learning 
studies reporting a dissociation between fear measures (e.g. Sevenster et al. 2014). 
Importantly, our US expectancies-based indices remained the most robustly associated with 
our ETA, which supports the use of US expectancies as measures of fear extinction with 
clinical relevance (Boddez et al., 2013). Although this has important practical implications 
because US ratings are easier to collect than psychophysiological measures, caution is 
warranted since such association was found for only one of the three ETA outcomes tested.  
In this study we used an “analog” sample, which is consistent with new initiatives in 
mental health research that focus on domains or constructs across a dimension of function 
rather than on clinical diagnoses (Haro et al., 2014; Insel et al., 2010). Previous research on 
the use of D-cycloserine as an “extinction enhancer” in phobic fears has produced 
contradictory results in clinical (where positive results have been achieved, e.g. Ressler et al., 
2004) and analog (where mostly negative results have been achieved, e.g. Guastella, Dadds, 
Lovibond, Mitchell, & Richardson, 2007) samples. When interpreting this contradiction, 
Grillon (2009) has proposed a “dual-model theory” of fear learning, according to which two 
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systems would be involved in fear learning in humans: a higher-order cognitive system 
(associated with the conscious awareness of danger) and an “automatic” lower-order system 
(independent of conscious awareness processes, and where D-cycloserine would act on). 
Lower-order processes could play a more important role in clinical than in analog phobic 
samples. Although exposure therapy probably taps into both higher order and lower order 
mechanisms (see Grillon, 2009), it is possible that some of our negative findings on the 
association between extinction measures and fear reduction measures depend on the use of an 
analog rather than a clinical sample. In a similar way, this could explain why our “higher 
order measures” (i.e. risk ratings) were a better predictor of fear reduction that our “lower 
order measures” (i.e. FPS). 
Our study has several strengths. We measured fear learning using a well-established 
paradigm with three different fear measures, while controlling for variables that are known to 
affect fear learning (menstrual cycle, time of the day). Moreover, our recruitment strategy 
avoided typical factors that confound fear learning experiments in anxious individuals 
(comorbidity, medication).  
In addition, we note various limitations. First, our sample was relatively small for 
some of the analyses, but is still much larger (n=50 versus n=24) than that used in a previous 
study on the association between fear extinction and exposure therapy (Ball et al. 2016).We 
computed post-hoc power (two-tailed) for our significant bivariate correlations using the 
sample size, the effect size, and the alpha error (.05). We had 68% power to detect a 
significant correlation between extinction learning and ETA (one-tailed 79%), and 59% to 
82% (one-tailed from 71% to 90%) for the other additional significant correlations. Thus, we 
had only moderate true power to accept our hypothesis. Second, in the paradigm employed 
here, conditioning and extinction learning occurred consecutively with no time for longer 
consolidation of fear conditioning. Third, our ETA was much shorter than the average 
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exposure therapy “in the clinic”. Our ETA cannot therefore be equated with exposure 
therapy, but rather as a model of exposure therapy that focuses on exposure principles. 
However, our data support a significant reduction in fear, and previous research has shown a 
significant fear reduction with similar “doses” of exposure therapy (e.g. Ball et al., 2016; 
Kleim et al., 2014; Müller et al., 2011). Single-day exposures have been proposed as a 
laboratory analog for clinical exposure therapy (Tsao & Craske, 2000). Importantly, there 
was sufficient variability in our ETA outcomes to examine individual differences. Fourth, 
fear of spiders involves also disgust, not only fear (Cisler, Olatunji, & Lohr, 2009). Although 
exposure-based treatments are effective in reducing spider fear (Olatunji, Huijding, De Jong, 
& Smits, 2011), it is unclear whether our results would replicate in other phobic fears. 
Finally, we did not conduct a follow-up study, and thus were unable to test whether these 
associations would remain significant over time. This is especially important for processes 
such as extinction recall. 
Notwithstanding these limitations, we have shown that fear extinction learning 
assessed in the laboratory is associated with the outcome of an ETA. These data may help to 
confirm that extinction learning is a valid pre-clinical model of exposure therapy and support 
current efforts to improve therapeutic outcomes by focusing on this process. Clarifying the 
role of other fear-learning processes (i.e., extinction recall) in the prediction of exposure-
based interventions awaits further research.  
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METHODS 
Fear learning paradigm  
We adapted the 2-day fear learning paradigm developed by Milad, Orr, Pitman, & Rauch 
(2005).  
The US (electric shock) had a duration of 100 ms and was generated by a Grass S48 
stimulator, transmitted via a constant current unit, and delivered to the volar surface of the 
non-dominant forearm using a bipolar bar electrode. It was adjusted for each participant to be 
‘definitely annoying but not painful’. Participants were told that they would see images of 
two different rooms during the experimental task and that they may or may not be shocked. 
They were also told that, in case they were shocked, it would be at the end of the presentation 
of the images.  
Before the experimental task, participants received four practice trials (in which the 
two CSs and the two contexts were combined). Then six startle probes were presented in 
order to further habituate responding. 
The procedure on the first part of day 2 was the same as on day 1, with the following 
exceptions: participants were told that the shock intensity selected the day before would be 
used; they were reminded of the instructions; and they were told that they had to use their 
memory of what they had learned the previous day to predict the occurrence of the US 
(shock). They did not receive any practice trials, and 10 habituation startle probes were 
presented before the extinction recall phase.  
Trial order was randomized across participants in blocks of nine trials (three of each 
type), with the restriction that no more than two trials of the same type occurred 
consecutively. Assignment of the rooms to the conditioning and the extinction contexts, and 
of the CS+ and the CS–, was counterbalanced across participants. 
 
Eduard Forcadell   36 
 
Recording and quantification (fear learning paradigm) 
Skin conductance response (SCR) 
Physiological measures were recorded using a Biopac 150 polygraph (BiopacSystems, Inc). 
SCR was recorded at the distal phalanges of the index and the middle fingers of the non-
dominant hand using two Ag-AgCl electrodes filled with electrolyte.  
 
Fear-potentiated startle (FPS) 
The startle blink was measured by recording the electromyographic activity (EMG) of the 
orbicularis oculi, using two 0.5 cm Ag-AgCl surface electrodes. The raw EMG signal was 
sampled at a rate of 2000 Hz, filtered (analogue 50-Hz notch filter; and digital infinite-
impulse-response, 28 to 500 Hz, band-pass filter), and rectified and smoothed offline (10-ms 
moving window average).  
 
Fear extinction indices 
The calculation of the fear extinction indices is shown in Table S1.  
 
Table S1. Calculation of fear extinction indices.  
 
 
 
 
 
 
 
 
 
 
 
 
 
CS+: Conditioned stimulus associated with the unconditioned stimulus during conditioning; CS-, Conditioned stimulus not associated with 
the unconditioned stimulus; US, Unconditioned stimulus; SCR, Skin Conductance Response; FPS, Fear-Potentiated startle. 
 EXTINCTION LEARNING Reference 
US expectancies   
SCR 
FPS 
100 – ([mean[(CS+) - (CS-)] during the last two trials of early extinction 
learning] / [mean[(CS+) - (CS-)] during first two trials of early extinction 
learning] * 100). 
Based on Pineles et al. (2016) 
 EXTINCTION RECALL  
US expectancies   
SCR Mean [(CS+) - (CS-)] during first two trials. Based on Rabinak et al. (2013) 
FPS   
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Exposure therapy analog 
During exposure therapy analog (ETA), interleaved phobic and neutral images were 
displayed on a computer monitor in front of the participant. Selection of the phobic and 
neutral images was made by two pilot participants who were shown a pre-selected set of 30 
pictures of spiders, which rated on a scale from 0 (no fear or anxiety) to 10 (severe fear or 
anxiety). In this study we used fifteen phobic images eliciting medium/strong fear/anxiety 
(i.e. scores between 5 and 8) and two neutral images (of a pen and a fork) eliciting no 
fear/anxiety (scores between 0 and 2).  
The VAS ratings (ranging from 0 (no fear/anxiety) to 10 (high fear/anxiety)) were 
averaged for each picture, yielding a total of 20 VAS scores for the phobic and 20 VAS 
scores for the neutral stimuli. 
 
RESULTS EXCLUDING PARTICIPANTS WITHOUT SUCCESSFUL FEAR 
CONDITIONING AND EXTINCTION LEARNING 
Our criteria for establishing successful fear conditioning were based on the work of Schiller, 
Raio, & Phelps (2012): the differential SCR to the CS+ and CS– by the end of the 
conditioning phase (mean of second half of the conditioning trials) had to be in the right 
direction (i.e. CS+ > CS–) and >0.1 μs for SCR, >1 µV for FPS or >1 point for US 
expectancies. Similarly, the criteria for establishing successful extinction learning were: 
differential SCR to the CS+ and CS– by the end of the late extinction learning phase (last 
trial) had to be ≤0.1 μs for SCR, ≤1 µV for FPS or ≤1 for US expectancies. For indices 
calculated as a percentage, extreme values (i.e. >150% or <-150%) were excluded.  
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Fear learning paradigm results 
 
Extinction learning 
For SCR and FPS and for the whole sample, we found evidence of successful extinction 
learning (i.e. similar response to the CS+ and CS- in the last block of extinction), as shown 
by a non-significant CS type main effect and a non-significant CS type × Block interaction 
(ps > .284). Analyses of US expectancies for the whole sample revealed a main effect of CS 
type (F(1, 47) = 7.16, p = .010,   
  = .132) but a non-significant CS type × Block interaction 
(p = .096).  
 
Extinction recall 
For FPS and for the whole sample, we found evidence of successful extinction recall (i.e. 
similar response to the CS+ and CS- in the extinction context during the first block of 
extinction recall), as shown by a non-significant CS type main effect and a non-significant 
CS type × Block interaction (ps > .372). For US expectancies and SCR, we found no 
evidence of extinction recall for the whole sample [significant CS type × Block interaction 
for US expectancies: F(2, 86) = 13.90, p < .001,   
  = .24; and for SCR: F(2, 32) = 5.31, p < 
.001,   
  = .25]. 
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Table S2. Alternative fear extinction indices.  
 
CS+, Conditioned stimulus associated with the unconditioned stimulus during the conditioning phase; CS+, Conditioned stimulus never 
associated with the unconditioned stimulus; US, Unconditioned stimulus; SCR, Skin Conductance Response; FPS, Fear-Potentiated startle. 
 
  
Extinction learning Reference 
Mean SCR [(CS+) - (CS-)] of first two trials - mean [(CS+) - (CS-)] of last two trials during extinction learning Soeter & Kindt, 2010 
100 – ([mean SCR during the last four CS+ trials of extinction learning / largest SCR of a CS+ trial during conditioning] * 100) Rabinak et al., 2014 
Mean SCR [(CS+) - (CS-)] of early extinction learning - mean SCR [(CS+) - (CS-)] of last two trials of conditioning Pineles et al., 2016 
Mean SCR [(CS+) - (CS-)] of late extinction learning - mean SCR [(CS+) - (CS-)] of early extinction learning Pineles et al., 2016 
Extinction recall  
100 – ([SCR of first CS+ trial during extinction recall / largest SCR of a CS+ trial during conditioning] * 100) Milad et al., 2005 
100 – ([mean SCR [(CS+) - (CS-)] of first two trials of extinction recall / largest SCR [(CS+) - (CS-)] during conditioning] * 100) Milad et al., 2006 
100 – (mean SCR of first two CS+ trials of extinction recall / largest SCR of a CS+ trial during conditioning] * 100) Milad et al., 2007 
100 – (mean SCR of first four CS+ trials of extinction recall / largest SCR of a CS+ trial during conditioning] * 100) Milad et al., 2009 
100 – ([mean SCR of first two CS+ trials of extinction recall / mean SCR of the two largest CS+ responses during conditioning] * 
100) 
Hartley et al., 2011 
Mean SCR [(CS+) - (CS-)] of first five trials during extinction recall Pineles et al., 2016 
Mean SCR [(CS+) - (CS-)] of first five trials during extinction recall - mean SCR [(CS+) - (CS-)] of early extinction learning.  Pineles et al., 2016 
Mean SCR [(CS+) - (CS-)] of first five trials during extinction recall - mean SCR [(CS+) - (CS-)] of late extinction learning. Pineles et al., 2016 
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